Skip to main content
. Author manuscript; available in PMC: 2021 Oct 1.
Published in final edited form as: Arthritis Care Res (Hoboken). 2020 Oct;72(10):1474–1480. doi: 10.1002/acr.24031

Table 2.

Comparing patient characteristics between those with high vs. medium/low adherence.

Patient characteristics High adherence (n=65) Medium/low adherence (n=165) p-value
Age, years, median [IQR] 61 [57–69] 53 [38–64] <0.001
Unemployed, % 19 8 0.01
Disability, % 2 9 0.04
Married/live with a partner, % 83 66 0.01
≥20 years living in the US, % 62 41 0.005
Immigration age, years, mean (SD) 42 (14) 35 (13) 0.001
Medication Regimen Complexity, median [IQR] 14 [10–19] 10 [7–15] <0.001
Rheumatic Medication Regimen Complexity, median [IQR] 8 [6–12] 7 [5–10] 0.01
Traditional Chinese medicine use, % 65 44 0.005
Sleep disturbance, median T-score [IQR] 49 [42–53] 53 [45–56] 0.02
Cognitive general concerns, median T-score [IQR] 33 [26–38] 37 [30–40] 0.04
Anxiety, median T-score [IQR] 43 [36–55] 52 [42–57] 0.02
Depression, median T-score [IQR] 43 [37–55] 50 [37–57] 0.09
Pain interference, median T-score [IQR] 57 [50–63] 57 [52–63] 0.8
Fatigue, mean T-score (SD) 50 (10) 52 (10) 0.07
Physical function, median T-score [IQR] 42 [37–52] 45 [39–52] 0.11
Ability to Participate in SRAs, median T-score [IQR] 60 [52–62] 58 [51–66] 0.7
Instrumental support, median T-score [IQR] 51 [47–56] 47 [45–51] 0.007

IQR = interquartile range; SD = standard deviation; SRA = social roles and activities